Market News How it works Learn FAQ
| RCT 0.0827 8.67% | NU 12.59 -16.95% | EWZ 34.15 -19.82% | BBD 2.93 -28.01% | TGL 0.2427 9.57% | AZTR 1.53 113.99% | ITUB 7.7 -20.37% | XP 15.705 -48.36% | NVD 3.99 -4.77% | SRTM 0.3 -30.28% | WFF 0.0898 12.25% | SPCX 146.9 -0.40% | PBR 22.5 -13.99% | SHFS 0.094 -29.00% | SOXL 90.5 8.31% | INTC 90.47 4.04% | VALE 12 -3.23% | NVDA 216 2.39% | CLRO 4.97 52.92% | NOK 8.64 6.14% | JBLU 2.37 -9.71% | TSLL 10.76 10.25% | CRWV 55.19 1.76% | GCDT 0.1545 -12.27% | SOXS 47.98 -8.54% | RIG 6.53 1.87% | NWGL 0.0869 5.98% | ABEV 2.83 -14.24% | RWM 14.5 -0.34% | BITO 10.65 -1.66% | AAL 12.2 0.74% | GPUS 0.1785 5.68% | TSLG 5.38 10.47% | T 20.85 -0.38% | SGRY 23.25 47.62% | IREN 25.43 2.11% | INTR 4.68 -34.91% | SBS 4.73 -26.09% | NFLX 63.9 -2.96% | GRAB 2.71 -2.87% | TSLA 391.62 5.21% | QID 14.22 -2.27% | WULF 11.98 5.83% | TQQQ 68.43 3.23% | CIFR 7.71 -2.90% | RBNE 0.17 -10.53% | SID 0.9118 -22.73% | SPDN 8.5 -0.47% | VZ 43.1 -3.49% | LUCD 0.5007 21.82%
NVInvitae Corporation logo

Invitae Corporation (NVTAQ)

Other OTC · Currency in USD
$0.00 ▼ 0.00 (-25.00%)
At close: Aug 7, 2:12 PM ET. Market closed.

Summary

Previous Close
$0.00
Open
$0.00
Day's Range
$0.00 – $0.00
52 Week Range
$0.00 – $1.09
Volume
84,678
Avg. Volume
246,659
Market Cap
$85.95K
Beta (5Y Monthly)
2.80
PE Ratio (TTM)
--
EPS (TTM)
$0.00
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Invitae Corporation

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Full-time employees
1,700
CEO
Kenneth D. Knight

Invitae Corporation (NVTAQ) operates as a medical genetics enterprise, striving to advance healthcare outcomes by furnishing crucial genetic information to individuals across the United States, Canada, and other international markets. The company's diverse offerings include genetic diagnostic services for various clinical domains, such as hereditary cancer risk assessment, targeted oncology, women's health concerns, rare medical conditions, and pharmacogenomics (the study of how genes affect a person's response to drugs). Additionally, Invitae delivers innovative digital health solutions and comprehensive health data management services.

Earnings

DateEst.Actual
Mar 6, 2024-$0.31-$0.31Beat
Nov 8, 2023-$0.32-$0.10Beat
Aug 8, 2023-$0.37-$0.30Beat
May 9, 2023-$0.40-$0.37Beat
Dec 31, 2022-$0.55-$0.41Beat
Nov 8, 2022-$0.63-$0.42Beat

Analyst view

Rating: Hold
Buy 25% · Hold 42% · Sell 33%

Get free alerts on NVTAQ and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.